Luis Villafaña-Diaz

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Electronic Health Record

Machine Learning

Top Venues

Pharmaceutical patent analyst

Expert opinion on drug discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Luis Villafaña-Diaz, Juan C Perez-Garcia, Diana Barron-Villaverde, Perez-Santos Martin
Patenting trends by Mexican pharmaceutical companies. Pharmaceutical patent analyst 12 (6) (2024)
Luis Villafaña-Diaz, Juan C Perez-Garcia, Diana Barron-Villaverde, Perez-Santos Martin
Patenting trends by Mexican pharmaceutical companies. Pharmaceutical patent analyst 12 (6) (2024)
Luis Villafaña-Diaz, Juan C Perez-Garcia, Diana Barron-Villaverde, Perez-Santos Martin
Patenting trends by Mexican pharmaceutical companies. Pharmaceutical patent analyst (2024)
Nemesio Villa-Ruano, Vianey Marin-Cevada, Gabriela Sánchez Esgua, Luis Villafaña-Diaz, Perez-Santos Martin
Drug repurposing of rimantadine for treatment of cancer. Pharmaceutical patent analyst (2023)
Nemesio Villa-Ruano, Maricruz Anaya-Ruiz, Luis Villafaña-Diaz, Diana Barron-Villaverde, Perez-Santos Martin
Drug repurposing of Mito-Atovaquone for cancer treatment. Pharmaceutical patent analyst (2023)
Perez-Santos Martin, Maricruz Anaya-Ruiz, Luis Villafaña-Diaz, Gabriela Sánchez Esgua
Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents. Expert opinion on drug discovery (2022)
Perez-Santos Martin, Maricruz Anaya-Ruiz, Gabriela Sánchez Esgua, Luis Villafaña-Diaz, Diana Barron-Villaverde
Treatment of solid tumors using bispecific anti-PDL-1/ICOS antibody. Pharmaceutical patent analyst 10 (2) (2021)